Titlebook: Current Cardiovascular Drugs; William H. Frishman (Professor of Medicine and Pha Book 2000Latest edition Springer Science+Business Media N

excursion

Angiotensin-Converting Enzyme Inhibitors,failure (CHI). An intravenous agent, ., has been approved by the Food and Drug Administration (FDA) for use in hypertension, and ten oral agents—.—are approved and available in the United States. . has also been approved by the FDA for the treatment of hypertension; however, this agent has not been

良心

Angiotensin-II Receptor Blockers,The effector hormone of the RAS is angiotensin II, which maintains the systemic vascular resistance and extracellular fluid volume through its direct and indirect vasoconstrictive and blood volume expansion effects (Fig. 4.1). In particular, angiotensin II constricts vascular smooth muscle and incre

弯腰

Antiarrhythmic Agents,inly used to treat supraventricular tachyarrhythmias. Azimilide, with its unique pharmacological profile, may prove to be a beneficial agent in the treatment of ventricular tachyarrhythmias. In addition, the implantable cardioverter defibrillator has become a standard therapy for life-threatening ve

MEET

Antithrombotic Therapy,ularly in arteries. Anticoagulant therapy is used to prevent clots from forming or extending by inhibiting the formation of the fibrin framework of the blood clot. Thrombolytic therapy activates the enzyme pathways that lyse the fibrin meshwork of the blood dot to restore blood flow after a dot has

disrupt

Beta-Adrenergic Blockers,myocardial contractility are reduced with beta blockade. Beta receptors are also found in a wide range of other tissues. These agents are generally well tolerated, and are widely used for various cardiovascular and other clinical conditions.

chalice

Calcium Antagonists, vasodilator agents, such as nitroglycerin. The mechanism of action of verapamil was initially thought to be a result of coronary vasodilatation and blockade of myocardial beta adrenergic receptors. Later, however, it was shown that the mechanism of action was not related to beta receptor blockade b

大厅